Stocksigma LogoStocksigma Logo

Kwality Pharmaceuticals Reports Strong Q2FY27 Results and Raises FY27 Revenue Guidance

Kwality Pharmaceuticals delivered robust Q2FY27 results, with revenue rising 62% YoY and 12% QoQ to ₹181.2 Cr

Kwality Pharmaceuticals Reports Strong Q2FY27 Results and Raises FY27 Revenue Guidance

Kwality Pharmaceuticals Ltd · Investor Presentation · 12 Nov 2026, 6:43 pm

Kwality Pharmaceuticals Reports Strong Q2FY27 Results and Raises FY27 Revenue Guidance Kwality Pharmaceuticals delivered robust Q2FY27 results, with revenue rising 62% YoY and 12% QoQ to ₹181.2 Cr. EBITDA surged 96% YoY to ₹49.8 Cr, with margins expanding to 27.5%, while PAT surged 106% YoY to ₹29.0 Cr. Strong execution and working capital discipline reduced the cash conversion cycle to 130 days in H1FY27. Following solid performance, management raised FY27 revenue guidance to ₹720+ Cr (from ₹700+ Cr) and targeted ₹1,000+ Cr by FY29, supported by ongoing capacity expansions in biologics, oncology, and hormones.

Original exchange filing (PDF)

More announcements from Kwality Pharmaceuticals Ltd

All Kwality Pharmaceuticals Ltd announcements